Barclays PLC Eloxx Pharmaceuticals, Inc. Transaction History

Barclays PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $2,280 - $5,921	-3,678 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$1.22 - $2.0 $3,385 - $5,550	-2,775 Reduced 43.0%	3,678 $6,000
Q2 2021 Aug 13, 2021	SELL	$1.35 - $3.36 $21,363 - $53,172	-15,825 Reduced 71.03%	6,453 $13,000
Q1 2021 May 13, 2021	BUY	$3.02 - $4.54 $41,304 - $62,093	13,677 Added 159.02%	22,278 $74,000
Q4 2020 Feb 11, 2021	SELL	$2.42 - $4.48 $8,547 - $15,823	-3,532 Reduced 29.11%	8,601 $34,000
Q3 2020 Nov 12, 2020	SELL	$2.53 - $3.4 $6,150 - $8,265	-2,431 Reduced 16.69%	12,133 $31,000
Q2 2020 Aug 12, 2020	BUY	$1.56 - $3.65 $9,684 - $22,659	6,208 Added 74.29%	14,564 $45,000
Q1 2020 May 13, 2020	SELL	$1.96 - $7.96 $33,480 - $135,972	-17,082 Reduced 67.15%	8,356 $16,000
Q4 2019 Feb 10, 2020	BUY	$3.19 - $7.56 $39,173 - $92,836	12,280 Added 93.33%	25,438 $187,000
Q3 2019 Nov 14, 2019	SELL	$4.37 - $9.91 $6,432 - $14,587	-1,472 Reduced 10.06%	13,158 $59,000
Q2 2019 Aug 14, 2019	BUY	$8.77 - $12.49 $62,126 - $88,479	7,084 Added 93.88%	14,630 $146,000
Q1 2019 May 15, 2019	BUY	$10.45 - $13.94 $78,855 - $105,191	7,546 New	7,546 $88,000
Q4 2018 Feb 14, 2019	SELL	$10.43 - $17.39 $87,674 - $146,180	-8,406 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.95 - $19.63 $81,606 - $134,053	6,829 Added 433.04%	8,406 $143,000
Q2 2018 Aug 14, 2018	BUY	$8.75 - $23.27 $13,798 - $36,696	1,577 New	1,577 $27,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.